BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 8865907)

  • 1. Does the response to hepatitis B vaccination predict CAPD-associated infections?
    Holley JL
    Adv Perit Dial; 1996; 12():218-20. PubMed ID: 8865907
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The influence of nutritional status, dialysis adequacy, and residual renal function on the response to hepatitis B vaccination in peritoneal dialysis patients.
    Dacko C; Holley JL
    Adv Perit Dial; 1996; 12():315-7. PubMed ID: 8865927
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An analysis of ten-year trends in infections in adults on continuous ambulatory peritoneal dialysis (CAPD).
    Bernardini J; Holley JL; Johnston JR; Perlmutter JA; Piraino B
    Clin Nephrol; 1991 Jul; 36(1):29-34. PubMed ID: 1889148
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Staphylococcus aureus CAPD-related infections are associated with nasal carriage.
    Lye WC; Leong SO; van der Straaten J; Lee EJ
    Adv Perit Dial; 1994; 10():163-5. PubMed ID: 7999818
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Staphylococcus aureus nasal carriage and infection in patients on continuous ambulatory peritoneal dialysis.
    Luzar MA; Coles GA; Faller B; Slingeneyer A; Dah GD; Briat C; Wone C; Knefati Y; Kessler M; Peluso F
    N Engl J Med; 1990 Feb; 322(8):505-9. PubMed ID: 2300122
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effectiveness of mupirocin preventing Staphylococcus aureus in catheter-related infections in peritoneal dialysis.
    Thodis E; Passadakis P; Panagoutsos S; Bacharaki D; Euthimiadou A; Vargemezis V
    Adv Perit Dial; 2000; 16():257-61. PubMed ID: 11045306
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of Staphylococcus nasal colonization and HIV in end-stage renal failure patients undergoing peritoneal dialysis.
    Ndlovu KCZ; Swe Swe-Han K; Assounga A
    Ren Fail; 2019 Nov; 41(1):303-313. PubMed ID: 30991864
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Staphylococcus aureus skin carriage and development of peritonitis in patients on continuous ambulatory peritoneal dialysis.
    Sesso R; Draibe S; Castelo A; Sato I; Leme I; Barbosa D; Ramos O
    Clin Nephrol; 1989 May; 31(5):264-8. PubMed ID: 2736815
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of once-a-week vs thrice-a-week application of mupirocin on methicillin and mupirocin resistance in peritoneal dialysis patients: three years of experience.
    Cavdar C; Saglam F; Sifil A; Celik A; Atay T; Gungor O; Ozder A; Gulay Z; Camsari T
    Ren Fail; 2008; 30(4):417-22. PubMed ID: 18569916
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effects of once- or thrice-weekly mupirocin application on mupirocin resistance in patients on continuous ambulatory peritoneal dialysis--first 6 months' experience.
    Cavdar C; Zeybel M; Atay T; Sifil A; Sanlidag C; Gulay Z; Camsari T
    Adv Perit Dial; 2004; 20():62-6. PubMed ID: 15384797
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A prospective study of peritoneal dialysis-related infections in CAPD patients with diabetes mellitus.
    Lye WC; Leong SO; van der Straaten JC; Lee EJ
    Adv Perit Dial; 1993; 9():195-7. PubMed ID: 8105922
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Replacement of the peritoneal dialysis catheter in persistent peritonitis in continuous ambulatory peritoneal dialysis].
    Marichal JF; Faller B; Mengus C; Wagner JD; Frey G
    Nephrologie; 1985; 6(1):7-10. PubMed ID: 4000380
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevention of staphylococcal peritonitis in CAPD patients combining ablution and mupirocin.
    Al-Hwiesh AK; Abdul Rahman IS
    Saudi J Kidney Dis Transpl; 2008 Sep; 19(5):737-45. PubMed ID: 18711288
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vaccination for prevention of CAPD associated staphylococcal infection: results of a prospective multicentre clinical trial.
    Poole-Warren LA; Hallett MD; Hone PW; Burden SH; Farrell PC
    Clin Nephrol; 1991 May; 35(5):198-206. PubMed ID: 1855327
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dialysis catheter infection related peritonitis: incidence and time dependent risk.
    Crabtree JH; Siddiqi RA
    ASAIO J; 1999; 45(6):574-80. PubMed ID: 10593689
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of sodium fusidate and ofloxacin on Staphylococcus aureus colonization and infection in patients on continuous ambulatory peritoneal dialysis.
    Sesso R; Parisio K; Dalboni A; Rabelo T; Barbosa D; Cendoroglo M; Pignatari A; Draibe S; Ajzen H
    Clin Nephrol; 1994 Jun; 41(6):370-6. PubMed ID: 8076441
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rates and causes of peritonitis in a National Multicenter Continuous Ambulatory Peritoneal Dialysis program in Sudan: first-year experience.
    Abu-Aisha H; Elhassan EA; Khamis AH; Fedail H; Kaballo B; Abdelraheem MB; Ali T; Medani S; Tammam L; Basheir I
    Saudi J Kidney Dis Transpl; 2007 Nov; 18(4):565-70. PubMed ID: 17951944
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatitis B vaccination in predialysis chronic renal failure patients a comparison of two vaccination schedules.
    McNulty CA; Bowen JK; Williams AJ
    Vaccine; 2005 Jul; 23(32):4142-7. PubMed ID: 15913854
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of intradermal hepatitis B vaccination compared to intramuscular vaccination in hemodialysis patients.
    Chanchairujira T; Chantaphakul N; Thanwandee T; Ong-Ajyooth L
    J Med Assoc Thai; 2006 Aug; 89 Suppl 2():S33-40. PubMed ID: 17044452
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antibody response to Engerix-B and Recombivax-HB hepatitis B vaccination in end-stage renal disease.
    Lacson E; Teng M; Ong J; Vienneau L; Ofsthun N; Lazarus JM
    Hemodial Int; 2005 Oct; 9(4):367-75. PubMed ID: 16219057
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.